Current techniques used for the radiologic assessment of intracranial neoplasms

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 2, 2007, Pages 252-260

  Debnam, J Matthew ^a   Ketonen, Leena ^a   Hamberg, Leena M ^a   Hunter, George J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; CREATINE PHOSPHATE; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; INOSITOL; N ACETYLASPARTIC ACID; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ASTROCYTOMA; BRAIN ANGIOGRAPHY; BRAIN BLOOD FLOW; BRAIN METABOLISM; BRAIN PERFUSION; BRAIN TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLIOBLASTOMA; HUMAN; INTRACRANIAL TUMOR; MAGNETIC RESONANCE ANGIOGRAPHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; RADIODIAGNOSIS; RELIABILITY; REVIEW; TUMOR DIAGNOSIS;

BRAIN NEOPLASMS; DIAGNOSTIC IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33846986293     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Bash S, Villablanca JP, Jahan R, et al. Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography. Am J Neuroradiol. 2005;26:1012-1021.
2. Casey SO, Alberico RA, Patel M, et al. Cerebral CT venography. Radiology. 1996;198:163-170.
3. Matsumoto M, Kodama N, Sakuma J, et al. 3D-CT arteriography and 3D-CT venography: the separate demonstration of arterial-phase and venous-phase on 3D-CT angiography in a single procedure. Am J Neuroradiol. 2005;26:635-641.
4. Hirai T, Korogi Y, Ono K, et al. Prospective evaluation of suspected stenoocclusive disease of the intracranial artery: combined MR angiography and CT angiography compared with digital subtraction angiography. Am J Neuroradiol. 2002;23:93-101.
5. Ochi RP, Vieco PT, Gross CE. CT angiography of cerebral vasospasm with conventional angiographic comparison. Am J Neuroradiol. 1997;18:265-269.
6. Anderson GB, Ashforth R, Steinke DE, et al. CT angiography for the detection of cerebral vasospasm in patients with acute subarachnoid hemorrhage. Am J Neuroradiol. 2000;21:1011-1015.
7. Hirai T, Korogi Y, Ono K, et al. Preoperative embolization for meningeal tumors: evaluation of vascular supply with angio-CT. Am J Neuroradiol. 2004;25:74-76.
8. Moringlane JR, Bartylla K, Hagen T, et al. Stereotactic neurosurgery planning with 3-D spiral CT-angiography. Minim Invasive Neurosurg. 1997;40:83-86.
9. Wetzel S, Kirsch E, Stock KW, et al. Cerebral veins: comparative study of CT venography with intraarterial digital subtraction angiography. Am J Neuroradiol. 1999;20:249-255.
10. Hoeffner EG, Case I, Jain R, et al. Cerebral perfusion CT: technique and clinical applications. Radiology. 2004;231:632-644.
11. Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. Am J Neuroradiol. 2003;24:1989-1998.
12. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology. 1994;191:41-51.
13. Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology. 1999;211:791-798.
14. Sugahara T, Korogi Y, Tomiguchi S, et al. Post-therapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. Am J Neuroradiol. 2000;21:901-909.
15. Hazle JD, Jackson EF, Schomer DF, Leeds NE. Dynamic imaging of intracranial lesions using fast spin echo imaging: differentiation of brain tumors and treatment effects. J Magn Reson Imaging. 1997;7:1084-1093.
16. Maia ACM Jr, Malheiros SMF, da Rocha AJ, et al. MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. Am J Neuroradiol. 2005;26:777-783.
17. Lev MH, Rosen BR. Clinical applications of intracranial perfusion MR imaging. Neuroimag Clin N Am. 1999;9:309-331.
18. Roberts HC, Roberts TPL, Brasch RC, Dillon WP. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. Am J Neuroradiol. 2000;21:891-899.
19. Dowling C, Bollen AW, Noworolskiet SM, et al. Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. Am J Neuroradiol. 2001;22:604-612.
20. Chernov M, Hayashi M, Izawa M, et al. Differentiation of the radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases: importance of multi-voxel proton MRS. Minim Invasive Neurosurg. 2005;48:228-234.
21. Majós C, Julià-Sapé M, Alonsoet J, et al. Brain tumor classification by proton MR spectroscopy: comparison of diagnostic accuracy at short and long TE. Am J Neuroradiol. 2004;25:1696-1704.
22. Schlemmer HP, Bachert P, Herfarth KK, Zuna I, Debus J, van Kaick G. Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. Am J Neuroradiol. 2001;22:1316-1324.
23. Yetkin F, Mueller WM, Morris GL, et al. Functional MR activation correlated with intraoperative cortical mapping. Am J Neuroradiol. 1997;18:1311-1315.
24. Langleben D, Segall GM. PET in differentiation of recurrent brain tumor from radiation injury. J Nuclear Med. 2000;41:1861-1867.